Pharmafile Logo

Fresenius Kabi Ltd.

Fresenius Kabi is the leading European provider of clinical nutrition and infusion therapy offering a unique and comprehensive range of products and services for both hospital and home settings. From our expertise in nutrition and infusion therapies, and through dedication to people through innovation we are committed to becoming the preferred partner worldwide for saving, treatment and caring for chronically ill patients.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Cestrian Court, Eastgate Way, Runcorn, Cheshire, WA7 1NT
+44 (0) 1928-533 533

 Latest Content from PMHub 

Drive, Discover, Dive_OPEN Health

Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.

Novel Oncology Therapies Require Innovative Methods in Oncology Modeling

Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.

Patient Support Program (PSP) Optimization: A Customer Story

Our client was looking to gather detailed feedback on their Patient Support Program (PSP) in order to improve its useability, offerings, and value to patients and caregivers. Working closely with...

Spotting the Signs of Dementia is the First Step to Diagnosis

As part of our contribution to dementia awareness week, we wanted to help ground people in the terms often used interchangeably to describe dementia.

The future for Pharmacists is here

Videos and Podcasts | May 12, 2023 | CHASE

CHASE and Medacy will be in attendance at this year's Clinical Pharmacy Congress (CPC) on 12 - 13 May 2023 at the ExCeL Centre in London.

CHASE and Medacy will be attending Clinical Pharmacy Congress 2023

Press Releases | May 12, 2023 | CHASE

CHASE and Medacy will be in attendance at this year's Clinical Pharmacy Congress (CPC) on 12 - 13 May 2023 at the ExCeL Centre in London.

Caroline Pond joins CHASE as NHS Partnership Working Director

Press Releases | May 12, 2023 | CHASE

CHASE is delighted to welcome Caroline Pond as NHS Partnership Working Director.

Real-World Impact of Continuing Medical Education on Physician Behavior in Prevention of Migraine

During the Alliance For Continuing Education in the Health Professions Industry Summit Medscape Education was awarded a Best in Class designation for its use of Real-World Outcomes to measure the impact of...

New syndicated reports now available

Living with CD, PsO, IPF & PF-ILD 2023

Hyper-personalisation – The immediate future of pharma is personalised.

What does hyper-personalisation in Pharma look like?